ArticleFrontiers in medicine2026
Criminalizing genomic discrimination: protecting human dignity under UAE and French law.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The rapid advancement of genomics and biotechnology has introduced complex legal and ethical challenges, foremost among them genomic discrimination: the use of individuals' genetic traits, family medical history, or inferred genetic status to make adverse decisions in employment, insurance, access to services, or other legally significant contexts. Such practices undermine human dignity, equality, privacy, and trust in institutions. Methods: Using descriptive-analytical and comparative methods, we analyze the adequacy and effectiveness of criminal-law protections against genomic discrimination in the United Arab Emirates (UAE) and France. We examine the scope of protected genetic information, the constitutive elements of the offense, applicable sanctions, attempted discrimination, aggravating circumstances, and emerging risks arising from familial and forensic uses of genetic data. Results: Both jurisdictions prohibit discrimination based on genetic characteristics, but important gaps remain regarding attempted offenses, aggravating circumstances, inferred genetic information, and the expanding use of familial and genealogical genetic data. In the UAE, the Human Genome Law expressly prohibits and criminalizes genomic discrimination, while French law prohibits discrimination based on genetic characteristics through its Civil and Penal Codes. Discussion: We recommend clearer criminal provisions addressing attempts, proportionate and cumulative sanctions where appropriate, explicit aggravating circumstances, and safeguards against discriminatory uses of inferred, familial, forensic, and genealogical genetic information. These reforms would strengthen protection of human dignity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.